New Zealand's Medicinal Cannabis Export Surge: A High-Value Opportunity

David Seymour, New Zealand's Associate Minister of Health and Minister for Regulation, has expressed optimism about the country's potential to become a significant exporter of medicinal cannabis, likening it to the success of the New Zealand wine industry. A recent Ministry of Health report revealed that New Zealand exported over one tonne of cannabis flower in 2024, a substantial increase from 485.6 kilograms in 2023, 184.3 kilograms in 2022, and 49 kilograms in 2021. The primary markets for these exports include Australia, Portugal, and Uruguay.

Newstalk ZBThe New Zealand Herald

The surge in exports has been attributed to recent regulatory changes that have eased barriers for exporters. Vendors are required to obtain a medicinal cannabis licence and apply to Medsafe for a controlled drug export licence for each shipment. The average processing time for these applications was reported to be 10 days in the 2024/25 financial year. Medsafe has implemented measures to streamline the application process, including automating invoice procedures and prioritizing export applications wherever feasible.

The New Zealand Herald

Seymour highlighted the economic benefits of the medicinal cannabis industry, stating, “We need to get money into the country, and not everybody likes this stuff, but there’s a market for it.” He emphasized the government's commitment to reducing red tape and bureaucracy, aiming to provide exporters with more permanent licences. Medsafe has also committed to balancing regulatory requirements with the need for businesses to operate effectively, indicating ongoing engagement with the sector to identify further improvements.

The New Zealand Herald

While there is support for the growth of the medicinal cannabis industry, some critics may express concerns regarding the implications of increased cannabis exports, particularly in relation to public health and safety. However, specific dissenting viewpoints were not detailed in the sources.

Newstalk ZB

• “New Zealand could become, just as we are with wine, a high-value powerhouse.” — David Seymour, Associate Minister of Health and Minister for Regulation

The New Zealand Herald

• “As a result of improvements within Medsafe, export licences are being processed 56% faster than in 2023, and we’re looking into further improvements.” — David Seymour

The New Zealand Herald

• “In a million little ways, the Ministry for Regulation is cutting red tape. Not everybody wants a puff of the green, but for those who do, there’s a market. If they’re not harming anyone else, we should let them.” — David Seymour

The New Zealand Herald

• “While the effect of the improvements will take time to flow through, timeframes are already improving.” — Medsafe Statement

Newstalk ZB

Looking ahead, the Ministry of Health and Medsafe are expected to continue refining the export process and engaging with the medicinal cannabis sector to facilitate further growth. This ongoing dialogue may lead to additional regulatory changes aimed at enhancing the efficiency of the export framework.

The New Zealand Herald